# DAWN (Day One Biopharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Day One Biopharmaceuticals, Inc. reported $158.2M in revenue and a net loss of $107.3M for the fiscal year ended December 31, 2025 (up 20.6% year over year), with a -80.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/DAWN
- Markdown: https://convexityos.com/fundamentals/DAWN.md
- SEC CIK: 0001845337
- Reporting currency: USD
- Latest filing period: December 31, 2025
- Last synced: Nov 20, 2026, 05:22 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001845337&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $158.2M | +20.6% YoY |
| Operating Income | FY 2025 | -$127.8M | -80.8% margin |
| Net Income | FY 2025 | -$107.3M | -67.8% net margin |
| Diluted EPS | FY 2025 | -$1.04 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$104.1M | -65.8% FCF margin |
| Cash & ST Investments | Dec 31, 2025 | $441.1M | Total debt: $2.79M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $158.2M | $131.2M | $0 | $0 | -- | -- | -- |
| Research & Development | $148.1M | $227.7M | $130.5M | $85.62M | $43.58M | $9.10M | $13.90M |
| Total Operating Expenses | $285.9M | $348.4M | $206.1M | $146.9M | $72.74M | $13.78M | $14.90M |
| **Operating Income** | -$127.8M | -$217.3M | -$206.1M | -$146.9M | -$72.74M | -$13.78M | -$14.90M |
| **EBITDA** | -$127.4M | -$217.2M | -$206.0M | -$146.8M | -$72.72M | -$13.77M | -$14.90M |
| Income Tax Expense | -$1.98M | $7.14M | $0 | $0 | -- | -- | -- |
| **Net Income** | -$107.3M | -$95.50M | -$188.9M | -$142.2M | -$70.64M | -$40.51M | -$12.63M |
| Basic EPS | -$1.04 | -$1.02 | -$2.37 | -$2.17 | -$4.62 | -$7.33 | -$2.13 |
| **Diluted EPS** | -$1.04 | -$1.02 | -$2.37 | -$2.17 | -$4.62 | -$7.33 | -$2.13 |
| Basic Shares Outstanding | 103.2M | 93.2M | 79.8M | 65.5M | 37.0M | 5.5M | 5.9M |
| Diluted Shares Outstanding | 103.2M | 93.2M | 79.8M | 65.5M | 37.0M | 5.5M | 5.9M |

### Income Statement (Quarterly)

| Line Item | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $53.72M | $39.80M | $33.91M | $30.76M | $29.21M | $93.76M | $8.19M | $0 |
| Research & Development | $40.95M | $31.42M | $36.15M | $39.62M | $61.82M | $33.56M | $92.11M | $40.21M |
| Total Operating Expenses | $81.18M | $64.05M | $68.88M | $71.83M | $94.54M | $64.12M | $123.0M | $66.77M |
| **Operating Income** | -$27.46M | -$24.25M | -$34.97M | -$41.07M | -$65.33M | $29.64M | -$114.8M | -$66.77M |
| **EBITDA** | -$27.37M | -$24.16M | -$34.88M | -$40.97M | -$65.29M | $29.65M | -$114.8M | -$66.74M |
| Income Tax Expense | -$1.98M | $0 | $0 | $0 | $6.47M | -$882K | $1.55M | $0 |
| **Net Income** | -$21.28M | -$19.73M | -$30.32M | -$36.00M | -$65.71M | $37.04M | -$4.41M | -$62.41M |
| Basic EPS | -- | -$0.19 | -$0.29 | -$0.35 | -- | $0.38 | -$0.05 | -$0.72 |
| **Diluted EPS** | -- | -$0.19 | -$0.29 | -$0.35 | -- | $0.38 | -$0.05 | -$0.72 |
| Basic Shares Outstanding | -- | 103.4M | 103.1M | 102.7M | -- | 96.6M | 87.1M | 86.7M |
| Diluted Shares Outstanding | -- | 103.4M | 103.1M | 102.7M | -- | 96.9M | 87.1M | 86.7M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $197.1M | $125.0M | $230.8M | $85.26M | $284.3M | $43.73M |
| Short-Term Investments | $244.0M | $406.8M | $135.6M | $257.0M | $0 | -- |
| **Cash & Short-Term Investments** | $441.1M | $531.7M | $366.3M | $342.3M | $284.3M | $43.73M |
| Accounts Receivable, Net | $26.73M | $13.88M | $0 | -- | -- | -- |
| Inventory | $6.33M | $3.32M | $0 | -- | -- | -- |
| Other Current Assets | -- | -- | -- | $347.9M | $289.4M | $45.07M |
| **Total Current Assets** | $485.1M | $562.3M | $375.3M | $347.9M | $289.4M | $45.07M |
| Property, Plant & Equipment, Net | $2.14M | $2.29M | $208K | $20K | $57K | $77K |
| Intangible Assets | $18.02M | $15.63M | $0 | -- | -- | -- |
| **Total Non-Current Assets** | $22.73M | $20.46M | $774K | $1.19M | $453K | $590K |
| **Total Assets** | $507.8M | $582.8M | $376.0M | $349.1M | $289.8M | $45.66M |
| Accounts Payable | $3.73M | $3.26M | $2.58M | $260K | $1.74M | $202K |
| Deferred Revenue (Current) | $2.00M | $1.55M | $0 | -- | -- | -- |
| **Total Current Liabilities** | $60.52M | $73.45M | $29.51M | $16.61M | $8.66M | $2.00M |
| Deferred Revenue (Non-Current) | $3.04M | $3.23M | $0 | -- | -- | -- |
| Other Non-Current Liabilities | $484K | $761K | $0 | -- | -- | -- |
| **Total Non-Current Liabilities** | $6.14M | $6.59M | $0 | $408K | $16K | $204K |
| **Total Liabilities** | $66.67M | $80.04M | $29.51M | $17.02M | $8.67M | $2.20M |
| **Total Debt (incl. Leases)** | $2.79M | $2.60M | $408K | $813K | $220K | $402K |
| Common Stock | $10K | $10K | $9.0K | $7.0K | $6.0K | -- |
| Retained Earnings | -$661.4M | -$554.1M | -$458.6M | -$269.7M | -$127.5M | -$56.84M |
| Accumulated Other Comp. Income | $65K | $84K | $9.0K | -$71K | $0 | -- |
| **Total Stockholders' Equity** | $441.2M | $502.8M | $346.5M | $332.0M | $281.1M | -$54.20M |
| Total Equity | $441.2M | $502.8M | $346.5M | $332.0M | $281.1M | -$54.20M |

### Balance Sheet (Quarterly)

| Line Item | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $197.1M | $43.28M | $35.62M | $33.36M | $125.0M | $422.8M | $239.6M | $270.4M |
| Short-Term Investments | $244.0M | $408.3M | $417.5M | $439.7M | $406.8M | $135.6M | $122.2M | $47.55M |
| **Cash & Short-Term Investments** | $441.1M | $451.6M | $453.1M | $473.0M | $531.7M | $558.4M | $361.9M | $317.9M |
| Accounts Receivable, Net | $26.73M | $16.70M | $19.67M | $18.05M | $13.88M | $8.70M | $9.14M | -- |
| Inventory | $6.33M | $7.06M | $6.54M | $3.56M | $3.32M | $2.73M | $151K | -- |
| **Total Current Assets** | $485.1M | $490.0M | $494.4M | $508.7M | $562.3M | $581.0M | $383.2M | $326.0M |
| Property, Plant & Equipment, Net | $2.14M | $2.23M | $2.32M | $2.51M | $2.29M | $904K | $196K | $185K |
| Intangible Assets | $18.02M | $18.82M | $19.61M | $20.41M | $15.63M | -- | -- | -- |
| **Total Non-Current Assets** | $22.73M | $23.81M | $24.61M | $25.70M | $20.46M | $19.81M | $17.28M | $611K |
| **Total Assets** | $507.8M | $513.8M | $519.0M | $534.4M | $582.8M | $600.8M | $400.4M | $326.6M |
| Accounts Payable | $3.73M | $5.78M | $5.09M | $2.54M | $3.26M | $3.02M | $6.44M | $4.78M |
| Deferred Revenue (Current) | $2.00M | $2.32M | $1.85M | $1.64M | $1.55M | $1.46M | -- | -- |
| **Total Current Liabilities** | $60.52M | $56.47M | $51.22M | $47.88M | $73.45M | $39.74M | $93.71M | $29.84M |
| Deferred Revenue (Non-Current) | $3.04M | $2.95M | $3.37M | $3.35M | $3.23M | $3.06M | -- | -- |
| Other Non-Current Liabilities | $484K | $761K | $761K | $761K | $761K | -- | -- | -- |
| **Total Non-Current Liabilities** | $6.14M | $6.45M | $6.98M | $6.96M | $6.59M | $5.60M | $0 | $0 |
| **Total Liabilities** | $66.67M | $62.91M | $58.20M | $54.84M | $80.04M | $45.34M | $93.71M | $29.84M |
| **Total Debt (incl. Leases)** | $2.79M | $2.89M | $3.00M | $2.92M | $2.60M | $2.62M | $190K | $300K |
| Common Stock | $10K | $10K | $10K | $10K | $10K | $10K | $9.0K | $9.0K |
| Retained Earnings | -$661.4M | -$640.1M | -$620.4M | -$590.1M | -$554.1M | -$488.4M | -$525.4M | -$521.0M |
| Accumulated Other Comp. Income | $65K | $69K | -$92K | -$52K | $84K | -$6.0K | -$22K | -$5.0K |
| **Total Stockholders' Equity** | $441.2M | $450.9M | $460.8M | $479.5M | $502.8M | $555.5M | $306.7M | $296.8M |
| Total Equity | $441.2M | $450.9M | $460.8M | $479.5M | $502.8M | $555.5M | $306.7M | $296.8M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$107.3M | -$95.50M | -$188.9M | -$142.2M | -$72.75M | -$43.84M | -$16.98M |
| Depreciation & Amortization | $366K | $92K | $36K | $63K | $20K | $16K | $0 |
| Stock-Based Compensation | $44.39M | $48.26M | $39.34M | $27.24M | $13.32M | $526K | $111K |
| Change in Receivables | -$12.86M | -$13.88M | $0 | $0 | -- | -- | -- |
| Change in Payables | $471K | $686K | $2.32M | -$1.48M | $1.54M | $132K | $14K |
| **Operating Cash Flow** | -$103.8M | -$78.11M | -$146.9M | -$109.9M | -$48.54M | -$13.49M | -$4.51M |
| Capital Expenditure | -$320K | -$2.17M | -$224K | -$26K | $0 | -$92K | $0 |
| **Free Cash Flow** | -$104.1M | -$80.28M | -$147.1M | -$109.9M | -$48.54M | -$13.58M | -$4.51M |
| **Investing Cash Flow** | $174.6M | -$231.0M | $128.4M | -$255.1M | -$8.00M | -$92K | $0 |
| Common Stock Issued | $0 | $0 | $161.4M | $161.6M | $167.0M | $0 | $0 |
| **Financing Cash Flow** | $1.22M | $203.3M | $164.0M | $165.9M | $297.1M | $29.98M | $30.91M |
| **Net Change in Cash** | $72.11M | -$105.8M | $145.5M | -$199.0M | $240.6M | $16.40M | $26.39M |

### Cash Flow Statement (Quarterly)

| Line Item | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$21.28M | -$19.73M | -$30.32M | -$36.00M | -$65.71M | $37.04M | -$4.41M | -$62.41M |
| Depreciation & Amortization | $91K | $90K | $91K | $94K | $38K | $16K | $15K | $23K |
| Stock-Based Compensation | $11.07M | $9.56M | $10.90M | $12.86M | $11.04M | $11.55M | $13.03M | $12.64M |
| Change in Receivables | -$10.04M | $2.97M | -$1.61M | -$4.18M | -$5.18M | $441K | -$9.14M | $0 |
| Change in Payables | -$2.04M | $688K | $2.55M | -$722K | $245K | -$3.43M | $1.66M | $2.20M |
| **Operating Cash Flow** | -$14.15M | -$5.80M | -$24.81M | -$59.00M | -$30.01M | $50.75M | -$49.13M | -$49.73M |
| Capital Expenditure | $0 | $0 | -$3.0K | -$317K | -$1.42M | -$724K | -$26K | $0 |
| **Free Cash Flow** | -$14.15M | -$5.80M | -$24.81M | -$59.31M | -$31.43M | $50.03M | -$49.16M | -$49.73M |
| **Investing Cash Flow** | $167.5M | $13.46M | $26.32M | -$32.61M | -$269.6M | -$67.70M | $17.06M | $89.29M |
| **Financing Cash Flow** | $471K | $0 | $748K | $0 | $1.85M | $200.1M | $1.30M | $48K |
| **Net Change in Cash** | $153.8M | $7.66M | $2.26M | -$91.61M | -$297.8M | $183.1M | -$30.77M | $39.61M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -80.8% | -165.7% | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -67.8% | -72.8% | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -24.3% | -19.0% | -54.5% | -42.8% | -25.1% | -- | -- |
| Return on Assets (ROA) | -21.1% | -16.4% | -50.2% | -40.7% | -24.4% | -88.7% | -- |
| Current Ratio | 8.02x | 7.66x | 12.72x | 20.94x | 33.43x | 22.58x | -- |
| Quick Ratio | 7.91x | 7.61x | 12.72x | 20.60x | 32.84x | 21.91x | -- |
| Debt to Equity | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | -- | -- |
| **Revenue Growth (YoY)** | +20.6% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -80.8% | -123.9% | -59.5% | -118.3% | -165.7% | -- | -- | -- |
| **Net Profit Margin** | -67.8% | -113.5% | -50.6% | -42.7% | -72.8% | -- | -- | -- |
| Return on Equity (ROE) | -24.3% | -33.7% | -20.6% | -14.4% | -19.0% | -15.2% | -54.6% | -70.4% |
| Return on Assets (ROA) | -21.1% | -29.5% | -18.3% | -12.9% | -16.4% | -14.0% | -41.8% | -64.0% |
| Current Ratio | 8.02x | 8.68x | 9.65x | 10.62x | 7.66x | 14.62x | 4.09x | 10.93x |
| Quick Ratio | 7.91x | 8.55x | 9.53x | 10.55x | 7.61x | 14.55x | 4.09x | 10.66x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x |
| **Revenue Growth (YoY)** | +83.9% | -57.6% | +313.9% | -- | -- | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -181.8% | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -153.3% | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -150.0% | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -111.4% | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -111.6% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
